APA (7th ed.) Citation

CP, W., YC, L., BH, L., M, M., YT, C., YS, W., . . . SV, A. (2026). Lirafugratinib attenuates ABCG2-dependent drug efflux and restores chemosensitivity in multidrug-resistant nonsmall cell lung cancer cells. Drug metabolism and disposition: the biological fate of chemicals, 54(4), 100258. https://doi.org/10.1016/j.dmd.2026.100258

Chicago Style (17th ed.) Citation

CP, Wu, Li YC, Lin BH, Murakami M, Chang YT, Wu YS, Hung TH, and Ambudkar SV. "Lirafugratinib Attenuates ABCG2-dependent Drug Efflux and Restores Chemosensitivity in Multidrug-resistant Nonsmall Cell Lung Cancer Cells." Drug Metabolism and Disposition: The Biological Fate of Chemicals 54, no. 4 (2026): 100258. https://doi.org/10.1016/j.dmd.2026.100258.

MLA (9th ed.) Citation

CP, Wu, et al. "Lirafugratinib Attenuates ABCG2-dependent Drug Efflux and Restores Chemosensitivity in Multidrug-resistant Nonsmall Cell Lung Cancer Cells." Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 54, no. 4, 2026, p. 100258, https://doi.org/10.1016/j.dmd.2026.100258.